 The study aims to examine how non-small cell lung cancer NSCLC responds to matuzumab in combination with pemetrexed, as compared with giving pemetrexed alone. The study also aims to examine how safe and effective matuzumab is and for how long it stays in the body pharmacokinetics. Matuzumab is an experimental treatment which is currently only available for research studies. 